Impact of artificial intelligence on the diagnosis, treatment and prognosis of endometrial cancer
Authors:
- Samia Rauf Mbbs ButtSBSamia Rauf Mbbs Butt
- Amna Mbbs SoulatASAmna Mbbs Soulat
- Priyanka Mohan Mbbs LalPLPriyanka Mohan Mbbs Lal
- Hajar FakhorHFHajar Fakhor
- Siddharth Kumar PatelSPSiddharth Kumar Patel
- Mashal Binte Mbbs AliMAMashal Binte Mbbs Ali
- Suneel Mcps ArwaniSASuneel Mcps Arwani
- Anmol Mbbs MohanAMAnmol Mbbs Mohan
- Koushik Mbbs MajumderKMKoushik Mbbs Majumder
- Vikash KumarVKVikash Kumar
- Usha Pharm. D TejwaneyUTUsha Pharm. D Tejwaney
- Sarwan KumarSKSarwan Kumar
Open Access
- 17 January 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (3) , 1531-1539
Abstract
Endometrial cancer is one of the most prevalent tumours in females and holds an 83% survival rate within 5 years of diagnosis. Hypoestrogenism is a major risk factor for the development of endometrial carcinoma (EC) therefore two major types are derived, type 1 being oestrogen-dependent and type 2 being oestrogen independent. Surgery, chemotherapeutic drugs, and radiation therapy are only a few of the treatment options for EC. Treatment of gynaecologic malignancies greatly depends on diagnosis or prognostic prediction. Diagnostic imaging data and clinical course prediction are the two core pillars of artificial intelligence (AI) applications. One of the most popular imaging techniques for spotting preoperative endometrial cancer is MRI, although this technique can only produce qualitative data. When used to classify patients, AI improves the effectiveness of visual feature extraction. In general, AI has the potential to enhance the precision and effectiveness of endometrial cancer diagnosis and therapy. This review aims to highlight the current status of applications of AI in endometrial cancer and provide a comprehensive understanding of how recent advancements in AI have assisted clinicians in making better diagnosis and improving prognosis of endometrial cancer. Still, additional study is required to comprehend its strengths and limits fully.Keywords
This publication has 66 references indexed in Scilit:
- Revised FIGO Staging System for Endometrial CancerClinical Obstetrics and Gynecology, 2011
- Comparison of robotic-assisted surgery outcomes with laparotomy for endometrial cancer staging in TurkeyArchives of Gynecology and Obstetrics, 2010
- A Multiinstitutional Experience With Robotic-Assisted Hysterectomy With Staging for Endometrial CancerObstetrics & Gynecology, 2009
- Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2009
- Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniquesGynecologic Oncology, 2008
- Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatmentInternational Journal of Clinical Oncology, 2006
- Endometrial cancerThe Lancet, 2005
- Artificial intelligence in medicineThe Annals of The Royal College of Surgeons of England, 2004
- Current treatment options for endometrial cancerExpert Review of Anticancer Therapy, 2004
- Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding — a Nordic multicenter studyAmerican Journal of Obstetrics and Gynecology, 1995